Forschung am Robert-Bosch-Krankenhaus

The right mix: Therapies as individual as people themselves

How do medicinal products work? Which medicines guarantee an optimal therapy? Which medicines can be successfully combined for treatment? How can adverse drug reactions be avoided? These are questions the scientists at the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology (IKP) deal with on a daily basis - with the intention of being able to treat the patients at the Robert-Bosch-Krankenhaus as individually and specifically as possible. In doing so, they investigate questions of how the human body reacts to drugs (pharmacokinetics), and how the drugs influence the patient's bodily functions (pharmacodynamics). In both cases, hereditary factors can significantly influence the effects of drugs (pharmacogenetics). Clarifying this is a special focus of the IKP.

Passing on insights as a matter of course

Research revolutionises our knowledge. More knowledge leads to amazing innovations. This requires people who are willing to share their experience with others. Therefore, all departments of the Robert Bosch Hospital cooperate closely with the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology. The knowledge gained in this way is immediately incorporated into the further training of nursing staff and doctors - in weekly seminars, regular further training events and symposia.

Bringing together research and teaching

The scientists and academic staff pass their know-how on to the next generation. Their commitment also contributes to the high teaching standard at the University of Tübingen. The head of the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology is also the Chair of Clinical Pharmacology at the University of Tübingen and, as such, responsible for training medical students in drug therapy. The IKP personnel also supervise numerous foreign scholarship holders, visiting scientists and doctoral students who are interested in pharmacological issues and work at the Institute for Clinical Pharmacology. This international cooperation, with numerous overseas research groups, forms the essential foundation of the Institute.

Keeping an overview

There are many areas in which research is worth the while. But what should the focus be of the scientists at the Robert-Bosch-Krankenhaus and the IKP? The research priorities are defined and developed further in cooperation with a scientific advisory board. Presently, the Scientific Advisory Board, which is made up of experienced doctors and very successful natural scientists, has nine members. They are not in the hospital's employ, thereby ensuring a neutral assessment and review of all research projects and results.